Henoch-Schoenlein purpura-like lesions in IL12RB1 and IL12B defects-a multi-centric experience from India

Yamini Sharma1, Pallavi Nadig1, Jhumki Das1

  • 1Paediatric Allergy and Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Insights

Henoch-Schonlein purpura-like vasculitis can signal underlying genetic defects in IL12RB1/IL12B, often linked to bacterial infections in Mendelian Susceptibility to Mycobacterial Disease (MSMD) patients.

Area of Science:

  • Immunology
  • Genetics
  • Dermatology

Background:

  • Mendelian Susceptibility to Mycobacterial Disease (MSMD) is a rare genetic disorder typically causing intracellular infections.
  • Cutaneous manifestations, like Henoch-Schonlein purpura (HSP), are rare in MSMD patients with IL12RB1 or IL12B mutations.
  • This study investigates vasculitic manifestations in Indian MSMD patients and reviews existing literature.

Purpose of the Study:

  • To evaluate HSP-like vasculitic manifestations in genetically confirmed MSMD cases in India.
  • To identify potential associations between IL12RB1/IL12B defects and vasculitis.
  • To review literature for similar reported cases and associations.

Main Methods:

  • Nine pediatric patients with genetically proven MSMD and HSP-like vasculitis were studied.
  • Clinical, laboratory, histopathological, and genetic data were collected.
  • Skin biopsies, IgA levels, renal involvement, and infection history were analyzed, alongside a literature review.

Main Results:

  • Eight patients had IL12RB1 defects, one had an IL12B defect.
  • All patients presented with a purpuric rash on lower limbs, resembling HSP.
  • Leukocytoclastic vasculitis (LCV) was seen in 77.7%, with IgA deposits in 2/5; bacterial infections (Salmonella, Pandorea) were noted in 44.4% and 22.2% respectively.

Conclusions:

  • HSP-like vasculitic rash in MSMD patients is often associated with underlying bacterial infections, particularly with IL12RB1/IL12B defects.
  • These skin lesions serve as crucial clinical indicators for potential IL12RB1/IL12B deficiencies.
  • Antimicrobial therapy was effective in managing the condition.